The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial
Open accessAbstract
BACKGROUND: Integrated Treatment (IT) has proved effective in treating patients with Substance Use Disorders (SUD) co-occurring with severe Mental Disorders (MD), less is known about the effectiveness of IT for patients with SUD co-occurring with less severe MD.The aim of this study was to investigate the effectiveness of IT for patients with SUD co-occurring with anxiety and/or depression on the following parameters:1. The use of substances, as measured by the Alcohol Use Identification Test (AUDIT), the Drug Use Identification Test (DUDIT), and the Addiction Severity Index (EuropASI).2. The severity of psychiatric symptoms, as measured by the Symptom Check List 90 r (SCL 90R).3. The client's motivation for changing his/her substance use behaviour, as measured by the Substance Abuse Treatment Scale (SATSr). METHODS: This is a group randomized clinical trial comparing the effectiveness of IT to treatment as usual in Community Mental Health Centres (CMHCs). Five CMHCs were drawn to the Intervention Group (IG) and four CMHCs to the Control Group (CG). The allocation to treatment conditions was not blinded. New referrals were screened with the AUDIT and the DUDIT. Those who scored above the cut-off level of these instruments were assessed with the Structured Clinical Interview for DSM-IV 1 and 2. We included patients with anxiety and/or depression together with one or more SUDs. RESULTS: We included 55 patients in the IG and 21 in the CG. A linear multilevel model was used. Both groups reduced their alcohol and substance use during the trial, while there was no change in psychiatric symptoms in either group. However, the IG had a greater increase in motivation for substance use treatment after 12 months than had the CG with an estimate of 1.76, p = 0.043, CI95% (0.08; 3.44) (adjusted analyses). There were no adverse events. CONCLUSIONS: Integrated treatment is effective in increasing the motivation for treatment amongst patients with anxiety and/or depression together with SUD in outpatient clinics. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00447733.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Only one study considered multiple substances and this sample was still largely alcohol focused.(Wüsthoff et al., 2014)”
From A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders (2024) · cites this paper as Wüsthoff et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391 · cited 1×
“Background Substance use disorders (SUD) are among the most common mental disorders (MD) with lifetime prevalence between 15 and 27% [1-3].”
BackgroundSAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597 · cited 14×
“To be able to measure change in substance use during the 12 months of follow-up, the instructions for the AUDIT and the DUDIT were altered to cover substance use during the last 6 months instead of the original last 12 months.”
MethodInfluentialCONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · cited 1×
“Background Substance use disorders (SUD) are among the most common mental disorders (MD) with lifetime prevalence between 15 and 27% [1-3].”
BackgroundDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 1×
“This article is to a large extent structured as recommended by the Consort group for reporting on group RCTs [68-75].”
MethodMotivational interviewing: preparing people for change.
Miller, W. R., & Rollnick, S. (2002) · Guilford Press eBooks · Cited by 7,769
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04337-3 · Cited by 5,373
From best evidence to best practice: effective implementation of change in patients' care
Grol, R., & Grimshaw, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14546-1 · Cited by 4,531
(1991) · Medical Entomology and Zoology · Cited by 4,438
Research works printed but not linked: 7
- Minkoff K: Behavioral health recovery management service planning guidelines co-occurring psychiatric and substance use disorders. In Illinois Department of Human Services’ Office of Alcoholism and Substance Abuse, The Behavioral Health Recovery Management project, An initiative of Fayette Companies. Peoria, IL: Chestnut Health Systems, Bloomington, IL; and the University of Chicago Center for Psychiatric Rehabilitation; 2001:1–36.
- Rush B: Best practices concurrent mental health and substance use disorders. Edited by: Centre for Addiction and Mental Health. 2002, Ottawa, Ontario, Canada: Publications Health Canada
- First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). 2002, New York: Biometrics Research, New York State Psychiatric Institute
- Derogatis LR: The SCL-90 Manual I: Scoring, administration and procedures for the SCL-90. 1977, Baltimore: Johns Hopkins University School of Medicine, Clinical Psychometrics Unit
- Mueser KT, Drake RE, Clark RE, McHugo GJ, Mercer-McFadden C, Ackerson TH: Toolkit on evaluating substance abuse in persons with severe mental illness. 1995, Cambridge, MA: Human Services Research Institute
- IBM Corp: IBM SPSS Statistics for Windows, Version 20.0. 2011, Armonk, NY: IBM Corp
- Wüsthoff LE, Waal H, Gråwe RW: When Research Meets Reality- lessons Learned From a Pragmatic Multisite Group- Randomized Clinical Trial on Psychosocial Interventions in the Psychiatric and Addiction Field. Substance Abuse. 2012, 6: 95-106.
Cited by
Hildebrand, M. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.01.008 · Cited by 177
Abuse and misuse of antidepressants
Sullivan, M. A., & Evans, E. (2014) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s37917 · Cited by 118
“152 Integrated treatment for co-occurring disorders is associated with better treatment outcomes, but there is a wide range of approaches included in integrated treatment, including complementary and alternative therapies such as music and art therapy 153 or acupuncture therapy.”
Butler, A., Nicholls, T. L., Samji, H., Fabian, S., & Lavergne, M. R. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000927 · Cited by 78
Zheng, E. Z., Wong, N. M. L., Yang, A. S. Y., & Lee, T. M. C. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03003-w · Cited by 72
“The neural underpinnings of these two symptoms across clinical disorders and the co-occurrence of these two symptom categories are unclear [4 – 6], potentially contributing to the lack of effective treatments [7, 8].”
BackgroundBerg, M. K., Hobkirk, A. L., Joska, J. A., & Meade, C. S. (2016) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/tra0000207 · Cited by 42
Metadata
- Authors
- Wüsthoff, L. E., Waal, H., & Gråwe, R. W.
- Affiliations
- University of Oslo (NO)
- St Olav's University Hospital (NO)
- Corresponding author
- Wüsthoff, Linda E
- Venue
- BMC Psychiatry
- Published
- 2014-03-05
- Volume
- 14
- Issue
- 1
- Pages
- 67-67
- ISSN
- 1471-244X (ISSN-L)
- PMC
- PMC3974008
- OpenAlex
- W2036552387
- Cited by
- 46
- References
- 79
- Citations by year
- 2026: 10 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 1 · 2021: 8 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 4
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Psychiatry (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychiatric care and mental health services
- Keywords
- integrated treatment, substance use disorders, anxiety, depression, comorbidities, treatment motivation, alcohol consumption, drug use, psychiatric symptoms, community mental health centers, outpatient care
- MeSH terms
- Adult, Anxiety Disorders, Community Mental Health Centers, Depressive Disorder, Female, Humans, Male, Referral and Consultation, Treatment Outcome, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial. https://app.cochat.ai/papers/10.1186/1471-244x-14-67
- The paper
- Wüsthoff, L. E., Waal, H., & Gråwe, R. W. (2014). The effectiveness of integrated treatment in patients with substance use disorders co-occurring with anxiety and/or depression--a group randomized trial. BMC Psychiatry. https://doi.org/10.1186/1471-244x-14-67
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Flowchart of participants. Flowchart of patients in the Intervention Group (IG) and the Control Group (CG) [54].](https://figures.cochat.ai/paper-figures/9b25197c3e424b599e2f02c1df93c423/the-effectiveness-of-integrated-treatment-in-patients-with-substance-use-figure-1.jpg)